DGAP-News: AFFiRiS: Positive phase 1 results with immunotherapies targeting PCSK9 to treat hypercholesterolemia published by the European Journal of Clinical Pharmacology
DGAP-News: AFFiRiS AG / Key word(s): Study results AFFiRiS: Positive phase 1 results with immunotherapies targeting PCSK9 to treat hypercholesterolemia published by the European Journal of Clinical Pharmacology 27.05.2021 / 11:00 The issuer is solely responsible for the content of this announcem...
Source: boersennews.de